Development and Validation of Creatinine-Based Estimates of the Glomerular Filtration Rate Equation

Sponsor
University of Malaya (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05112393
Collaborator
(none)
200
1
13
15.4

Study Details

Study Description

Brief Summary

This study aim to recruit all Electronic Medical Record of patients who underwent for 51chromium ethylenediamine tetra acetic acid (51Cr-EDTA) imaging at the Nuclear Medicine Centre, University Malaya Medical Centre from September 2016 to September 2021. The data that collected will be analyzed to develop and validate a new equation to estimate Glomerular Filtration Rate that specifically for Malaysian multiracial population.

Condition or Disease Intervention/Treatment Phase
  • Other: Development of new estimating Glomerular Filtration Rate (eGFR) equation
  • Other: Validation of new estimating Glomerular Filtration Rate (eGFR) equation

Detailed Description

List of patients who underwent for 51Cr EDTA imaging at the Nuclear Medicine Centre, University Malaya Medical Centre from September 2016 to September 2021 will be obtained from relevant department. All patient's Electronic Medical Record (EMR) will be evaluated for recruitment into the study.

Demographics data of the patients that will be collected include age, gender, height, weight, and ethnicity. The clinical data that will be collected include CKD aetiology, background comorbidities, and vitals sign and laboratory data includes the renal function test. The 51Cr- EDTA readings were also recorded.

If there are multiple measurements of scans performed, the latest 51Cr-EDTA taken. The renal function test must be within three months of when the 51Cr-EDTA imaging was conducted.

Patients will be randomized into a development and validation cohort using a random number generated in Microsoft Excel. In the development cohort, a new equation will be developed using a nonlinear regression model utilizing a generalized least squares algorithm. Internal validation will be performed in the validation cohort, by comparing the bias, precision, and accuracy of the new equations and the other established equations to the measured GFR.

Study Design

Study Type:
Observational
Anticipated Enrollment :
200 participants
Observational Model:
Other
Time Perspective:
Cross-Sectional
Official Title:
Development and Validation of Creatinine-Based Estimates of the Glomerular Filtration Rate Equation From Chromium EDTA Imaging in the Multi-racial Malaysian Population
Anticipated Study Start Date :
Nov 1, 2021
Anticipated Primary Completion Date :
Aug 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Development Cohort

Half of the data will be randomized into development cohort by using a random number generated in Microsoft Excel. This cohort aim to develop a new estimating Glomerular Filtration Rate (eGFR) equation that produce accurate eGFR specifically in Malaysian multiracial population.

Other: Development of new estimating Glomerular Filtration Rate (eGFR) equation
Development Cohort: A new estimating Glomerular Filtration Rate(eGFR) equation will be developed by using a nonlinear regression model utilizing a generalized least squares algorithm.

Validation Cohort

Half of the data will be randomized into development cohort by using a random number generated in Microsoft Excel. This cohort aim to validate the newly developed estimating Glomerular Filtration Rate (eGFR) equation.

Other: Validation of new estimating Glomerular Filtration Rate (eGFR) equation
Validation Cohort: Internal validation will be performed by comparing bias, precision and accuracy of the new equations and the other established equations to the measured GFR.

Outcome Measures

Primary Outcome Measures

  1. New equation to estimate GFR that can be used specifically in Malaysian multiracial population [From 1st December 2021 to 31st December 2022]

    New equation that has its own ethnic coefficient that can produce accurate result in Malaysia multiracial population

Eligibility Criteria

Criteria

Ages Eligible for Study:
16 Years to 100 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Electronic Medical Records of patient scheduled for 51Cr EDTA imaging at the Nuclear Medicine Centre, University Malaya Medical Centre from September 2016 to September 2021

  • Age 16-year-old and above

Exclusion Criteria:
  • Electronic Medical Records of patients with missing data.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Malaya Medical Centre Kuala Lumpur Malaysia 59100

Sponsors and Collaborators

  • University of Malaya

Investigators

  • Principal Investigator: Ina Ismiarti Shariffuddin, University of Malaya

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
University of Malaya
ClinicalTrials.gov Identifier:
NCT05112393
Other Study ID Numbers:
  • eGFR MY
First Posted:
Nov 8, 2021
Last Update Posted:
Nov 8, 2021
Last Verified:
Oct 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Nov 8, 2021